STOCK TITAN

Alkermes to Participate in Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Alkermes plc (Nasdaq: ALKS) will participate in fireside chat presentations at two upcoming investor conferences, including the Piper Sandler 35th Annual Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference. The live webcasts can be accessed on www.alkermes.com and will be archived for 14 days.
Positive
  • None.
Negative
  • None.

DUBLIN, Nov. 21, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.

Piper Sandler 35th Annual Healthcare Conference
Date/Time: Tuesday, Nov. 28, 2023 at 11:00 a.m. ET (4:00 p.m. GMT)

6th Annual Evercore ISI HealthCONx Conference
Date/Time: Wednesday, Nov. 29, 2023 at 10:00 a.m. ET (3:00 p.m. GMT)

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Constantine
Investor Relations 
+1 781 873 2402

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-two-upcoming-investor-conferences-301995236.html

SOURCE Alkermes plc

FAQ

When will Alkermes plc participate in the Piper Sandler 35th Annual Healthcare Conference?

Alkermes plc will participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, Nov. 28, 2023 at 11:00 a.m. ET (4:00 p.m. GMT).

When will Alkermes plc participate in the 6th Annual Evercore ISI HealthCONx Conference?

Alkermes plc will participate in the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, Nov. 29, 2023 at 10:00 a.m. ET (3:00 p.m. GMT).

Where can the live webcasts be accessed?

The live webcasts can be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.06B
158.79M
1.25%
108.01%
8.58%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
DUBLIN 4

About ALKS

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.